Advertisement
Screener

GT BIOPHARMA, INC. (GTBP) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

GT BIOPHARMA, INC. Basic Shares Outstanding (Weighted Average)

GT BIOPHARMA, INC. (GTBP) reported Basic Shares Outstanding (Weighted Average) of 38.82 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14

  • GT BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 38.82M shares, a 1300.58% increase year-over-year.
  • GT BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 30.28M shares, a 1191.34% increase year-over-year.
  • GT BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 12.98M shares, a 474.86% increase year-over-year.
  • GT BIOPHARMA, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 3.94M shares, a 76.37% increase year-over-year.
  • GT BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 5.51M shares, a 190.57% increase from fiscal 2024.
  • GT BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 1.90M shares, a 40.78% increase from fiscal 2023.
  • GT BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.35M shares, a 26.87% increase from fiscal 2022.
  • GT BIOPHARMA, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 1.06M shares, a 96.23% decline from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 6 month as first filedWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-3038.82M shares
10-Q · filed 2026-08-14
34.58M shares
10-Q · filed 2026-08-14
27.36M shares
derived: average of 3 quarters · filed 2026-08-14
21.51M shares
derived: average of 4 quarters · filed 2026-08-14
2026-03-3130.28M shares
10-Q · filed 2026-05-15
21.63M shares
derived: average of 2 quarters · filed 2026-05-15
15.73M shares
derived: average of 3 quarters · filed 2026-05-15
12.49M shares
derived: average of 4 quarters · filed 2026-08-14
2025-12-3112.98M shares
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02
8.46M shares
derived: average of 2 quarters · filed 2026-03-06
6.56M shares
derived: average of 3 quarters · filed 2026-08-14
5.51M shares
10-K · filed 2026-03-02
2025-09-303.94M shares
10-Q/A · filed 2026-03-06
3.36M shares
derived: average of 2 quarters · filed 2026-08-14
3.03M shares
10-Q/A · filed 2026-03-06
2.83M shares
derived: average of 4 quarters · filed 2026-08-14
2025-06-302.77M shares
10-Q · filed 2026-08-14
2.56M shares
10-Q · filed 2026-08-14
2.46M shares
derived: average of 3 quarters · filed 2026-08-14
2.40M shares
derived: average of 4 quarters · filed 2026-08-14
2025-03-312.35M shares
10-Q · filed 2026-05-15
2.30M shares
derived: average of 2 quarters · filed 2026-05-15
2.28M shares
derived: average of 3 quarters · filed 2026-05-15
2.14M shares
derived: average of 4 quarters · filed 2026-05-15
2024-12-312.26M shares
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02
2.25M shares
derived: average of 2 quarters · filed 2026-03-06
2.07M shares
derived: average of 3 quarters · filed 2026-03-06
1.90M shares
10-K · filed 2026-03-02
2024-09-302.23M shares
10-Q/A · filed 2026-03-06
1.97M shares
derived: average of 2 quarters · filed 2026-03-06
1.78M shares
10-Q/A · filed 2026-03-06
1.68M shares
derived: average of 4 quarters · filed 2026-03-06
2024-06-301.71M shares
10-Q/A · filed 2026-03-06
1.55M shares
10-Q/A · filed 2026-03-06
1.49M shares
derived: average of 3 quarters · filed 2026-03-06
1.46M shares
derived: average of 4 quarters · filed 2026-03-06
2024-03-311.38M shares
10-Q · filed 2025-05-15
1.38M shares
derived: average of 2 quarters · filed 2025-05-15
1.38M shares
derived: average of 3 quarters · filed 2025-05-15
1.37M shares
derived: average of 4 quarters · filed 2025-05-15
2023-12-311.38M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21
1.37M shares
derived: average of 2 quarters · filed 2025-02-21
1.36M shares
derived: average of 3 quarters · filed 2025-02-21
1.35M shares
10-K · filed 2025-02-21
2023-09-301.37M shares
10-Q · filed 2024-11-14
41.02M shares
10-Q · filed 2023-11-01
1.35M shares
derived: average of 2 quarters · filed 2024-11-14
1.34M shares
10-Q · filed 2024-11-14
40.10M shares
10-Q · filed 2023-11-01
-21.78M shares
derived: average of 4 quarters · filed 2024-11-14
2023-06-301.34M shares
10-Q · filed 2024-08-14
40.17M shares
10-Q · filed 2023-08-07
1.32M shares
10-Q · filed 2024-08-14
39.63M shares
10-Q · filed 2023-08-07
-29.50M shares
derived: average of 3 quarters · filed 2024-08-14
-14.28M shares
derived: average of 4 quarters · filed 2024-08-14
2023-03-311.08M shares
10-Q · filed 2024-05-15
39.09M shares
10-Q · filed 2023-05-15
-44.92M shares
derived: average of 2 quarters · filed 2024-05-15
-19.49M shares
derived: average of 3 quarters · filed 2024-05-15
-6.81M shares
derived: average of 4 quarters · filed 2024-05-15
2022-12-31-90.92M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26
-29.77M shares
derived: average of 2 quarters · filed 2024-03-26
-9.43M shares
derived: average of 3 quarters · filed 2024-03-26
1.06M shares
10-K · filed 2024-03-26
31.87M shares
10-K · filed 2023-03-30
2022-09-3031.38M shares
10-Q · filed 2023-11-01
31.31M shares
derived: average of 2 quarters · filed 2023-11-01
31.72M shares
10-Q · filed 2023-11-01
32.47M shares
derived: average of 4 quarters · filed 2023-11-01
2022-06-3031.24M shares
10-Q · filed 2023-08-07
31.87M shares
10-Q · filed 2023-08-07
32.84M shares
derived: average of 3 quarters · filed 2023-08-07
32.47M shares
derived: average of 4 quarters · filed 2023-08-07
2022-03-3132.49M shares
10-Q · filed 2023-05-15
33.64M shares
derived: average of 2 quarters · filed 2023-05-15
32.88M shares
derived: average of 3 quarters · filed 2023-05-15
33.04M shares
derived: average of 4 quarters · filed 2023-05-15
2021-12-3134.79M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
33.08M shares
derived: average of 2 quarters · filed 2023-03-30
33.23M shares
derived: average of 3 quarters · filed 2023-03-30
28.16M shares
10-K · filed 2023-03-30
2021-09-3031.38M shares
10-Q · filed 2022-10-31
32.45M shares
derived: average of 2 quarters · filed 2022-10-31
25.95M shares
10-Q · filed 2022-10-31
2021-06-3033.52M shares
10-Q · filed 2022-08-15
24.93M shares
10-Q · filed 2022-08-15
2021-03-3116.24M shares
10-Q · filed 2022-05-16
2020-03-3170.08M shares
10-Q · filed 2020-05-15
2019-03-3151.09M shares
10-Q · filed 2020-05-15
-49.55M shares
derived: average of 2 quarters · filed 2020-05-15
-16.31M shares
derived: average of 3 quarters · filed 2020-05-15
-12.24M shares
derived: average of 4 quarters · filed 2020-05-15
2018-12-31-150.19M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-50.02M shares
derived: average of 2 quarters · filed 2019-03-29
-33.35M shares
derived: average of 3 quarters · filed 2019-03-29
50.24K shares
10-K · filed 2019-03-29
2018-09-3050.15M shares
10-Q · filed 2018-11-14
25.08M shares
derived: average of 2 quarters · filed 2018-11-14
50.13M shares
10-Q · filed 2018-11-14
20.86M shares
derived: average of 4 quarters · filed 2019-05-15
2018-06-30-0.18 shares
10-Q · filed 2018-08-14
-0.38 shares
10-Q · filed 2018-08-14
11.10M shares
derived: average of 3 quarters · filed 2019-05-15
12.33M shares
derived: average of 4 quarters · filed 2019-05-15
2018-03-3150.12M shares
10-Q · filed 2019-05-15
16.65M shares
derived: average of 2 quarters · filed 2019-05-15
16.44M shares
derived: average of 3 quarters · filed 2019-05-15
12.33M shares
derived: average of 4 quarters · filed 2019-05-15
2017-12-31-16.82M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-395.41K shares
derived: average of 2 quarters · filed 2019-03-29
-263.61K shares
derived: average of 3 quarters · filed 2019-03-29
16.77K shares
10-K · filed 2019-03-29
16.77M shares
10-K · filed 2018-03-01
2017-09-3016.03M shares
10-Q · filed 2018-11-14
8.01M shares
derived: average of 2 quarters · filed 2018-11-14
5.63M shares
10-Q · filed 2018-11-14
-12.86M shares
derived: average of 4 quarters · filed 2018-11-14
2017-06-30-5.14 shares
10-Q · filed 2018-08-14
479.05K shares
10-Q · filed 2017-08-11
-22.42 shares
10-Q · filed 2018-08-14
335.45K shares
10-Q · filed 2017-08-11
-22.48M shares
derived: average of 3 quarters · filed 2018-08-14
-10.00M shares
derived: average of 4 quarters · filed 2018-08-14
2017-03-31191.85K shares
10-Q · filed 2018-05-15
57.55M shares
10-Q · filed 2017-04-28
-33.73M shares
derived: average of 2 quarters · filed 2018-05-15
-13.33M shares
derived: average of 3 quarters · filed 2018-05-15
-4.16M shares
derived: average of 4 quarters · filed 2018-05-15
2016-12-31-67.64M shares
derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01
-20.09M shares
derived: average of 2 quarters · filed 2018-03-01
-5.62M shares
derived: average of 3 quarters · filed 2018-03-01
81.46K shares
10-K · filed 2018-03-01
24.43M shares
10-K/A · filed 2018-02-28
2016-09-3027.46M shares
10-Q/A · filed 2018-02-28
25.40M shares
derived: average of 2 quarters · filed 2018-02-28
22.66M shares
10-Q/A · filed 2018-02-28
17.65M shares
derived: average of 4 quarters · filed 2018-02-28
2016-06-3023.34M shares
10-Q/A · filed 2018-02-28
0.07 shares
10-Q · filed 2016-08-10
20.38M shares
10-Q/A · filed 2018-02-28
1.35 shares
10-Q · filed 2016-08-10
14.38M shares
derived: average of 3 quarters · filed 2018-02-28
11.39M shares
derived: average of 4 quarters · filed 2018-02-28
2016-03-3117.42M shares
10-Q/A · filed 2018-02-28
9.91M shares
derived: average of 2 quarters · filed 2018-02-28
7.41M shares
derived: average of 3 quarters · filed 2018-02-28
6.15M shares
derived: average of 4 quarters · filed 2018-02-28
2015-12-312.40M shares
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28
2.40M shares
derived: average of 2 quarters · filed 2018-02-28
2.40M shares
derived: average of 3 quarters · filed 2018-02-28
2.39M shares
10-K/A · filed 2018-02-28
2015-09-302.40M shares
10-Q/A · filed 2018-02-28
600.00M shares
10-Q · filed 2015-11-13
2.40M shares
derived: average of 2 quarters · filed 2018-02-28
2.39M shares
10-Q/A · filed 2018-02-28
598.17M shares
10-Q · filed 2015-11-13
2015-06-302.40M shares
10-Q/A · filed 2018-02-28
599.10M shares
10-Q · filed 2015-08-14
2.39M shares
10-Q/A · filed 2018-02-28
597.27M shares
10-Q · filed 2015-08-14
2015-03-312.38M shares
10-Q/A · filed 2018-02-28
595.44M shares
10-Q · filed 2015-05-14
2014-09-30590.06M shares
10-Q · filed 2015-11-13
581.55M shares
derived: average of 2 quarters · filed 2015-11-13
578.72M shares
10-Q · filed 2015-11-13
578.72M shares
10-Q · filed 2015-01-08
2014-06-30573.05M shares
10-Q · filed 2015-08-14
573.05M shares
10-Q · filed 2015-08-14
2014-03-31573.05M shares
10-Q · filed 2015-05-14
2013-09-30573.19M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-01-08
573.12M shares
derived: average of 2 quarters · filed 2015-01-08
564.54M shares
10-Q · filed 2015-01-08
2013-06-30573.05M shares
10-Q · filed 2015-01-08
560.22M shares
10-Q · filed 2015-01-08
2013-03-31547.25M shares
10-Q · filed 2015-01-08
2012-06-30329.27M shares
10-Q · filed 2014-12-12
306.13M shares
10-Q · filed 2014-12-12
2012-03-31282.98M shares
10-Q · filed 2014-12-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88